Quick Answer
Pulmatrix, Inc. reported R&D Expense of $38.0 thousand for fiscal year 2025.
Pulmatrix, Inc. R&D Expense — Annual History
| Fiscal Year | R&D Expense | YoY Change |
|---|---|---|
| 2025 | $38.0K | -99.5% |
| 2024 | $7.17M | -53.8% |
| 2023 | $15.52M | -14.9% |
| 2022 | $18.24M | +18.6% |
| 2021 | $15.38M | -1.5% |
| 2020 | $15.61M | +21.5% |
| 2019 | $12.85M | -0.9% |
| 2018 | $12.97M | +26.6% |
| 2017 | $10.24M | +0.9% |
| 2016 | $10.15M | +41.3% |
| 2015 | $7.19M | +230.0% |
| 2015 | $2.18M | -66.9% |
| 2014 | $6.59M | +376.8% |
| 2014 | $1.38M | — |
Quarterly R&D Expense
| Quarter Ending | R&D Expense | YoY | QoQ |
|---|---|---|---|
| September 30, 2025 | $8.0K | -99.0% | -42.9% |
| June 30, 2025 | $14.0K | -99.5% | -26.3% |
| March 31, 2025 | $19.0K | -99.5% | -97.7% |
| September 30, 2024 | $814.0K | -79.5% | -71.3% |
| June 30, 2024 | $2.83M | -32.0% | -19.3% |
| March 31, 2024 | $3.51M | -9.3% | -11.4% |
| September 30, 2023 | $3.96M | -25.0% | -4.8% |
| June 30, 2023 | $4.17M | -4.0% | +7.5% |
- Pulmatrix, Inc. showed a decrease of -99.5% in R&D Expense compared to the prior fiscal year.
- Over the 2014–2025 period, Pulmatrix, Inc.’s r&d expense has declined by 97.3% (from $1.38 million to $38.0 thousand).
- The most recent figure is from Pulmatrix, Inc.’s fiscal year 2025 report (Form 10-K), filed with the SEC on February 26, 2026.
- All figures are sourced from SEC EDGAR XBRL filings, last verified June 17, 2026.
Last verified: